Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: Data from the Italian cohort of ipilimumab expanded access programme (EAP).
Paolo Antonio Ascierto
Consultant or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; MedImmune; Merck Sharp & Dohme; Novartis; Roche/Genentech
Honoraria - Bristol-Myers Squibb; Merck Sharp & Dohme; Roche/Genentech
Ester Simeone
Honoraria - Bristol-Myers Squibb
Vanna Chiarion-Sileni
Consultant or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Roche/Genentech
Paola Queirolo
Consultant or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Roche/Genentech
Michele Del Vecchio
Research Funding - Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Novartis; Roche/Genentech
Lorenza Di Guardo
No relevant relationships to disclose
Massimo Guidoboni
No relevant relationships to disclose
Paolo Marchetti
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; Ipsen; Novartis; Sanofi
Other Remuneration - Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Pfizer
Gian Carlo Antonini Cappellini
No relevant relationships to disclose
Pier Francesco Ferrucci
Consultant or Advisory Role - Delcath Systems
Honoraria - Delcath Systems
Francesco Cognetti
No relevant relationships to disclose
Maria Grazia Bernengo
Consultant or Advisory Role - Bristol-Myers Squibb
Michele Guida
No relevant relationships to disclose
Riccardo Marconcini
No relevant relationships to disclose
Mario Mandala
Consultant or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline
Giorgio Parmiani
Consultant or Advisory Role - CureVac
Other Remuneration - Recombio
Gaetana Rinaldi
No relevant relationships to disclose
Massimo Aglietta
No relevant relationships to disclose
Luana Calabro
No relevant relationships to disclose
Michele Maio
Consultant or Advisory Role - Bristol-Myers Squibb
Honoraria - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb